Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Monomeric Amyloid Beta Regulates Microglia in Brain Developm
2026-07-13
Kwon et al. uncover a previously unrecognized signaling pathway in which monomeric amyloid beta (Aβ) acts as a negative regulator of microglial activation, crucial for proper neocortical assembly during mouse brain development. These findings challenge the solely pathological view of Aβ and suggest that monomer depletion may contribute to neurodevelopmental and neurodegenerative processes.
-
MLN8237 (Alisertib): Protocol Innovations in Cancer Biology
2026-07-13
MLN8237 (Alisertib) delivers highly selective Aurora A kinase inhibition, enabling robust apoptosis induction and tumor growth suppression in both in vitro and in vivo cancer models. This article decodes reference study breakthroughs and best-in-class workflows, offering advanced troubleshooting to maximize experimental clarity and reproducibility.
-
O-GlcNAcylation Drives Wnt-Induced Bone Formation via Glycol
2026-07-12
This study demonstrates that O-GlcNAcylation is essential for Wnt-stimulated bone formation by modulating glycolytic metabolism, particularly through stabilization of PDK1 in osteoblasts. These findings establish a mechanistic link between Wnt signaling, glucose metabolism, and osteogenesis, with implications for osteoporosis therapy and fracture healing.
-
Fucoidan Mitigates Irinotecan-Induced Steatohepatitis via Gu
2026-07-10
This study identifies the gut–liver axis and neutrophil extracellular traps (NETs) as central mechanisms in irinotecan-induced steatohepatitis, demonstrating that fucoidan administration preserves intestinal barrier integrity and curbs hepatic inflammation. The findings offer a mechanistic basis and practical approach for preventing chemotherapy-associated liver injury in oncology research.
-
Merbromin in Biochemical Research: Protein Probing & Antivir
2026-07-09
Merbromin stands out as a dual-purpose fluorescent probe and enzyme inhibition reagent, uniquely enabling high-sensitivity protein–ligand analysis and antiviral screening within the same workflow. This article translates the latest fluorimetric and antiviral studies into actionable protocols, troubleshooting, and cross-domain applications for advanced biochemical research.
-
Affinity-Purified Goat Anti-Rabbit IgG (H+L): HRP Antibody I
2026-07-09
The Affinity-Purified Goat Anti-Rabbit IgG (H+L), Horseradish Peroxidase Conjugated Secondary Antibody enables sensitive detection of rabbit IgG in immunoassays. Its specificity and signal amplification properties support robust applications in Western blot, ELISA, and IHC. This article provides evidence-backed benchmarks, workflow guidance, and clarifies application limits for reproducible research.
-
SHC-1 Inhibition Enhances CFTR Surface Abundance in Epitheli
2026-07-08
Barros et al. reveal that inhibition of SHC-1, a key MAPK pathway adaptor, can increase plasma membrane CFTR abundance in select epithelial cell models. Their findings refine our understanding of cell-type-specific regulation of CFTR trafficking and suggest new approaches for cystic fibrosis and secretory diarrhea research.
-
TiO2-Sonodynamic Therapy Induces Ferroptosis to Prevent PCO
2026-07-08
This study demonstrates that titanium dioxide nanoparticle–enhanced sonodynamic therapy (SDT) can prevent posterior capsular opacification (PCO) by inducing ferroptosis in lens epithelial cells. The findings establish a mechanistic link between ROS generation, GPX4 downregulation, and ferroptotic cell death, offering a promising non-invasive strategy to address PCO after cataract surgery.
-
5-Azacytidine: Applied Epigenetic Modulation in Cancer Model
2026-07-07
5-Azacytidine (5-AzaC) empowers translational workflows in cancer epigenetics, enabling robust DNA demethylation and gene reactivation. New research demonstrates its enhanced impact when paired with EZH2 inhibitors, opening avenues for immune modulation in resistant glioblastoma and hematologic malignancies.
-
ATS-9R: Precision Gene Silencing in Adipocytes for Metabolic
2026-07-07
ATS-9R (Adipocyte-targeting sequence-9-arginine) enables high-specificity, low-toxicity gene delivery to white adipose tissue, accelerating metabolic disease studies. Its unique Prohibitin-mediated endocytosis and robust in vivo performance offer researchers a decisive advantage in targeting adipose tissue inflammation and insulin resistance.
-
PRMT5 Inhibition Uncovers Spliceosomal and Metabolic Weaknes
2026-07-06
This study identifies a critical vulnerability in MYCN-amplified neuroblastoma, showing that selective PRMT5 inhibition disrupts both spliceosomal and metabolic pathways, particularly glutamine metabolism. The findings reveal a mechanistic link between epitranscriptomic regulation and metabolic adaptation, with implications for targeted cancer metabolism research.
-
BMS 309403: Precision FABP4 Inhibitor for Atherosclerosis Re
2026-07-06
BMS 309403 empowers researchers to dissect the FABP4 pathway with high specificity, enabling robust studies on lipid metabolism and inflammation in models of atherosclerosis and type 2 diabetes. This guide delivers protocol enhancements, troubleshooting, and translational insights to maximize experimental success.
-
Protease Inhibitor Cocktail: Precision in Protein Extraction
2026-07-05
The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) ensures comprehensive protein degradation prevention during cell lysis and extraction, maximizing sample integrity for downstream applications like Western blotting and co-immunoprecipitation. Its two-component, broad-spectrum formula empowers researchers with superior inhibition of serine, cysteine, aspartic proteases, and metalloproteases, outperforming generic inhibitors in sensitive workflows.
-
FLNa Suppression Promotes HEV Replication via NF-κB Pathway
2026-07-04
This study uncovers how HEV manipulates host cell cytoskeletal dynamics by inhibiting filamin A (FLNa), thereby blocking NF-κB signaling and enhancing viral replication. The findings provide new mechanistic insights into virus-host interactions and highlight the importance of cytoskeletal remodeling in viral immune evasion.
-
Zoledronic Acid: Applied Workflows for Cancer and Bone Resea
2026-07-03
Zoledronic Acid, a nitrogen-containing bisphosphonate, is redefining in vitro and in vivo cancer research through its potent anti-proliferative and pro-apoptotic effects. This guide delivers actionable protocols, troubleshooting strategies, and experimental insights, ensuring researchers harness the full translational potential of Zoledronic Acid from APExBIO.